Commission Implementing Regulation (EU) 2019/1589 of 26 September 2019 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances amidosulfuron, beta-cyfluthrin, bifenox, chlorotoluron, clofentezine, clomazone, cypermethrin, daminozide, deltamethrin, dicamba, difenoconazole, diflubenzuron, diflufenican, fenoxaprop-P, fenpropidin, fludioxonil, flufenacet, fosthiazate, indoxacarb, lenacil, MCPA, MCPB, nicosulfuron, picloram, prosulfocarb, pyriproxyfen, thiophanate-methyl, triflusulfuron and tritosulfuron
Proposed act with possible EEA relevance
Act under scrutiny by EEA EFTA
Draft Joint Committee Decision (JCD) under consideration
Entry into force of Joint Committee Decision (JCD) pending
Incorporated into the EEA Agreement and in force
Incorporated into the EEA Agreement but no longer in force
Legal status
EU legal act incorporated into the EEA Agreement by a Joint Committee Decision (JCD) Area (EEA Agreement)
II Technical Regulations, Standards, Testing and Certification
II.XV Dangerous Substances
Joint committee decision (JCD)
034/2020 In force in the EEA
Yes Legal documents
Commission Implementing Regulation (EU) 2019/1589 of 26 September 2019 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances amidosulfuron, beta-cyfluthrin, bifenox, chlorotoluron, clofentezine, clomazone, cypermethrin, daminozide, deltamethrin, dicamba, difenoconazole, diflubenzuron, diflufenican, fenoxaprop-P, fenpropidin, fludioxonil, flufenacet, fosthiazate, indoxacarb, lenacil, MCPA, MCPB, nicosulfuron, picloram, prosulfocarb, pyriproxyfen, thiophanate-methyl, triflusulfuron and tritosulfuron
Framkvæmdarreglugerð framkvæmdastjórnarinnar (ESB) 2019/1589 frá 26. september 2019 um breytingu á framkvæmdarreglugerð (ESB) nr. 540/2011 að því er varðar framlengingu á samþykkistímabilum fyrir virku efnin amíðósúlfúrón, betasýflútrín, bífenox, klórótólúrón, klófentesín, klómasón, sýpermetrín, damínósíð, deltametrín, díkamba, dífenókónasól, díflúbensúrón, díflúfeníkan, fenoxapróp-P, fenprópidín, flúdíoxóníl, flúfenaset, fosþíasat, indoxakarb, lenasíl, MCPA, MCPB, níkósúlfúrón, píklóram, prósúlfókarb, pýriproxýfen, þíófanatmetýl, tríflúsúlfúrón og trítósúlfúrón
Durchführungsverordnung (EU) 2019/1589 der Kommission vom 26. September 2019 zur Änderung der Durchführungsverordnung (EU)Nr. 540/2011 hinsichtlich der Verlängerung der Laufzeit der Genehmigung für die Wirkstoffe Amidosulfuron, beta-Cyfluthrin,Bifenox, Chlortoluron, Clofentezin, Clomazon, Cypermethrin, Daminozid, Deltamethrin, Dicamba, Difenoconazol, Diflubenzuron,Diflufenican, Fenoxaprop-P, Fenpropidin, Fludioxonil, Flufenacet, Fosthiazat, Indoxacarb, Lenacil, MCPA, MCPB, Nicosulfuron,Picloram, Prosulfocarb, Pyriproxyfen, Thiophanatmethyl, Triflusulfuron und Tritosulfuron
Kommisjonens gjennomføringsforordning (EU) 2019/1589 av 26. september 2019 om endring av gjennomføringsforordning (EU) nr. 540/2011 med hensyn til forlengelse av godkjenningsperiodene for de aktive stoffene amidosulfuron, beta-cyflutrin, bifenoks, klortoluron, klofentezin, klomazon, cypermetrin, daminozid, deltametrin, dikamba, difenokonazol, diflubenzuron, diflufenikan, fenoksaprop-P, fenpropidin, fludioksonil, flufenacet, fostiazat, indoksakarb, lenacil, MCPA, MCPB, nikosulfuron, pikloram, prosulfokarb, pyriproksyfen, tiofanatmetyl, triflusulfuron og tritosulfuron
History
21.03.2020
Adopted JCD confirmed entry into force date
21.03.2020
Compliance date in the EEA
20.03.2020
Adoption of Joint Commitee Decision (JCD) incorporating the act into the EEA Agreement
08.01.2020
Draft Joint Commitee Decision (JCD) incorporating the act into the EEA Agreement sent to Commission
26.09.2019
Adoption date in the EU
17.10.2019
Compliance date in the EU
Disclaimer: EEA-Lex is provided for information purposes only. The information is not guaranteed or promised to be current or complete and is not intended to replace any applicable legal sources.